Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
The Schmooze

‘In Treatment’ Goes American

Crossposted from Haaretz

Gabriel Byrne as therapist Paul Weston on ?In Treatment.? Image by HBO

Tonight treatment will start for three new patients in the third season of HBO’s “In Treatment.” This season will depend entirely on American scriptwriters, and according to Hagai Levi, who created the show that was originally an Israeli hit, that will only help the program.

“There was something in previous seasons that seemed like cross-breeding, since the source of the early seasons was so Israeli. Now the scriptwriters are entirely American, and it’s like watching an infant learn how to walk on its own,” says Levi. “It makes me happy to see that not everything moves according to the rules of globalization — that is to say, every place has its own problems. It’s impossible to use the same scriptwriters any place in the world. In my opinion, this will be the best season the series has had so far.” The Salon web magazine is expecting it to be “the darkest and gloomiest season yet.”

Read more at Haaretz.com

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.